Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Sonmez, S. Duru, Y. Saygideger, O. Sever, B. Onal, O. Ergul, G. Dikmen, S. Ardic (Ankara, Turkey). Leptin: in the diagnose of lung cancer. Eur Respir J 2009; 34: Suppl. 53, 2662

Member's Comments

No comment yet.

Related content which might interest you: Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 Lung cancer or cancer of the lung: a view from the bridge Source: Virtual Congress 2020 – Lung cancer or cancer of the lung Year: 2020 Tissue diagnosis in lung cancer Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010 Lung nodules in a lung cancer screening program: incidence density of lung cancer in patients with COPD and/or emphysema Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009 Serum hepcidin and iron are associated with non-small cell lung cancer stage Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008 Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 Surgically treated lung cancer patients: do they all smoke and would they all have been detected with lung cancer screening? Source: ERJ Open Res, 4 (3) 00001-2018; 10.1183/23120541.00001-2018 Year: 2018 Procalitonin: A prognosis factor in lung cancer and a marker for small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011 Pancreatic polypeptide is increased in patients with advanced malignant disease including lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 232s Year: 2002 Are serum leptin levels a prognostic factor in advanced lung cancer? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 Ghrelin does not influence cancer progression in a lung cancer cell line and mice with lung adenocarcinoma Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 How to treat lung cancer in IPF patients Source: Research Seminar 2015 Year: 2015 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Metastatic disease in non-small cell lung cancer: is it all the same? Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 The value of adiponectin as an inflammatory marker in lung cancer? Source: Annual Congress 2010 - Prognostic factors for lung cancer Year: 2010 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006